ulcerative colitis and tirzepatide GLP-1 Benefits For People With Obesity GLP-1 IBD obesity "inflammatory bowel

Verified Google reviews and patient videos shared directly to @slimfit.wellnesss_

[4] [5] The three primary subcutaneous injection sites used for comparable licensed therapies (such as semaglutide and tirzepatide, as described in their UK Summary of Product Characteristics) are: Abdomen the area around the stomach, avoiding the area immediately around the navel Front (anterolateral) thigh the outer-front portion of the upper thigh Upper arms the outer area of the upper arm, typically requiring assistance from another person for self-administration The abdomen is generally considered the most accessible and commonly used site, as it offers a relatively large surface area of subcutaneous fat and is straightforward to self-administer

Risk factors include age over 65 years, history of peptic ulcer disease, concurrent use of anticoagulants or corticosteroids, and prolonged NSAID therapy

EUGENE, Ore

10.1017/neu.2017.3 2 AguirreM.EckA.KoenenM

We prioritize individualized prescribing, starting with lower doses, monitoring your body's response, and increasing as needed over time